Assisted Reproductive Technology Market to 2027 - Global Analysis and Forecasts - by Technology (Artificial Insemination, In Vitro Fertilization, Surrogacy, and Others), By Procedure (Fresh Donor, Fresh Non Donor, Frozen Donor, Frozen Non Donor, and Embryo Banking), End User (Fertility Clinics, Hospitals, and Others), and Geography
Report Code: TIPBT00002177 No. of Pages: 150 Category: Biotechnology Status: Upcoming
Assisted reproductive technology is also known as fertility treatment that is used to perform infertility treatments. The procedure involve the removal of eggs from the woman ovaries that are combined with the sperms in the laboratory, further they returned to the woman's ovaries or are donated to another women. The technology used to elude the fertility problems while preserving the genetic connection. Moreover, the assisted reproductive technology is also used for couples who are discordant for certain communicable diseases, for instance, HIV to reduce the risk of infection when a pregnancy is desired.
The assisted reproductive technology market is anticipated to grow with a significant rate in the coming years, owing to factors such as, rising disposable income, growing number of smokers, drastically changed lifestyle causing various disorders such as stress, obesity and many other further drives the growth of the market. Moreover, rising prevalence of infertility problems and related conditions is the prime factor driving the growth of the assisted reproductive technology market. On the other hand, the fresh non donor segment is anticipated to dominate the global market for assisted reproductive technology in the forecast period.
The "Global Assisted Reproductive Technology Market Analysis to 2027" is a specialized and in-depth study of the medical device industry with a focus on the global market trend. The report aims to provide an overview of global assisted reproductive technology market with detailed market segmentation by technology, procedure, end-user, and geography. The global assisted reproductive technology market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.
The global assisted reproductive technology market is segmented on the basis of technology, procedure, and end-user. The technology segment includes, artificial insemination, in vitro fertilization, surrogacy, and others. The artificial insemination segment further classified into intrauterine insemination (IUI), intracervical insemination (ICI) and others. The in vitro fertilization segment is further bifurcated into intra-cytoplasmic sperm injection (ICSI) and preimplantation genetic diagnosis (PGD). On the basis of procedure, the assisted reproductive technology market is categorized into fresh donor, fresh non-donor, frozen donor, frozen non-donor, and embryo banking. Based on end users, the assisted reproductive technology market is classified into fertility clinics, hospitals, and other end user.3
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global assisted reproductive technology market based on technology, procedure, and end-user. It also provides market size and forecast till 2027 for overall assisted reproductive technology market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region.
Europe lead the ART market followed by North America due to increasing technological advancements, rising awareness among people for fertility treatment, rise in infertility rate and rising government initiatives. Moreover, the Centers for Disease Control and Prevention (CDC) developed a national public health action plan in this region for the detection, improving efficacy safe treatment, and prevention from infertility. Developing economies in Asia Pacific are likely to be vital to the global assisted reproductive technology market in the coming years, with the majority of growth primarily driven by late family planning and comparatively lower treatment cost, and government initiatives in developing countries is also likely to provide a major boost to the global assisted reproductive technology market in the coming years.
The report analyzes factors affecting the assisted reproductive technology market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.
The report also includes the profiles of key assisted reproductive technology manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years. Some of the key players influencing the market are Cosmos Biomedical Ltd., Microm Ltd., Irvine Scientific, Parallabs Ltd, Bloom Fertility Centre, Ferring B.V., OvaScience, Inc, KITAZATO CORPORATION., Vitrolife, and CooperSurgical Inc. among others.
The assisted reproductive technology market is anticipated to grow with a significant rate in the coming years, owing to factors such as, rising disposable income, growing number of smokers, drastically changed lifestyle causing various disorders such as stress, obesity and many other further drives the growth of the market. Moreover, rising prevalence of infertility problems and related conditions is the prime factor driving the growth of the assisted reproductive technology market. On the other hand, the fresh non donor segment is anticipated to dominate the global market for assisted reproductive technology in the forecast period.
The "Global Assisted Reproductive Technology Market Analysis to 2027" is a specialized and in-depth study of the medical device industry with a focus on the global market trend. The report aims to provide an overview of global assisted reproductive technology market with detailed market segmentation by technology, procedure, end-user, and geography. The global assisted reproductive technology market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.
The global assisted reproductive technology market is segmented on the basis of technology, procedure, and end-user. The technology segment includes, artificial insemination, in vitro fertilization, surrogacy, and others. The artificial insemination segment further classified into intrauterine insemination (IUI), intracervical insemination (ICI) and others. The in vitro fertilization segment is further bifurcated into intra-cytoplasmic sperm injection (ICSI) and preimplantation genetic diagnosis (PGD). On the basis of procedure, the assisted reproductive technology market is categorized into fresh donor, fresh non-donor, frozen donor, frozen non-donor, and embryo banking. Based on end users, the assisted reproductive technology market is classified into fertility clinics, hospitals, and other end user.3
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global assisted reproductive technology market based on technology, procedure, and end-user. It also provides market size and forecast till 2027 for overall assisted reproductive technology market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region.
Europe lead the ART market followed by North America due to increasing technological advancements, rising awareness among people for fertility treatment, rise in infertility rate and rising government initiatives. Moreover, the Centers for Disease Control and Prevention (CDC) developed a national public health action plan in this region for the detection, improving efficacy safe treatment, and prevention from infertility. Developing economies in Asia Pacific are likely to be vital to the global assisted reproductive technology market in the coming years, with the majority of growth primarily driven by late family planning and comparatively lower treatment cost, and government initiatives in developing countries is also likely to provide a major boost to the global assisted reproductive technology market in the coming years.
The report analyzes factors affecting the assisted reproductive technology market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.
The report also includes the profiles of key assisted reproductive technology manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years. Some of the key players influencing the market are Cosmos Biomedical Ltd., Microm Ltd., Irvine Scientific, Parallabs Ltd, Bloom Fertility Centre, Ferring B.V., OvaScience, Inc, KITAZATO CORPORATION., Vitrolife, and CooperSurgical Inc. among others.
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
2. KEY TAKEAWAYS
3. ASSISTED REPRODUCTIVE TECHNOLOGY MARKET LANDSCAPE
3.1. MARKET OVERVIEW
3.2. MARKET SEGMENTATION
3.2.1. Assisted Reproductive Technology Market - By Technology
3.2.2. Assisted Reproductive Technology Market - By Procedure
3.2.3. Assisted Reproductive Technology Market - By End User
3.2.4. Assisted Reproductive Technology Market - By Region
3.2.4.1. By Country
3.3. PEST ANALYSIS
3.3.1. North America - PEST Analysis
3.3.2. Europe - PEST Analysis
3.3.3. Asia Pacific - PEST Analysis
3.3.4. Middle East and Africa - PEST Analysis
3.3.5. South and Central America- PEST Analysis
4. ASSISTED REPRODUCTIVE TECHNOLOGY MARKET - KEY INDUSTRY DYNAMICS
4.1. KEY MARKET DRIVERS
4.2. KEY MARKET RESTRAINTS
4.3. KEY MARKET OPPORTUNITIES
4.4. FUTURE TRENDS
4.5. IMPACT ANALYSIS
5. ASSISTED REPRODUCTIVE TECHNOLOGY MARKET - GLOBAL ANALYSIS
5.1. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET OVERVIEW
5.2. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
5.3. MARKET POSITIONING/MARKET SHARE
5.4. PERFORMANCE OF KEY PLAYERS
5.5. CLINICAL TRIALS
5.6. EXPERT OPINIONS
6. ASSISTED REPRODUCTIVE TECHNOLOGY MARKET REVENUE AND FORECASTS TO 2027 - BY TECHNOLOGY
6.1. OVERVIEW
6.2. TECHNOLOGY MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
6.3. ARTIFICIAL INSEMINATION MARKET
6.3.1. Overview
6.3.2. Artificial Insemination Market Revenue Forecasts and Analysis (US$ Mn)
6.3.3. Intrauterine Insemination (IUI) Market
6.3.3.1. Overview
6.3.3.2. Intrauterine Insemination (IUI) Market Revenue Forecasts and Analysis (US$ Mn)
6.3.4. Intracervical Insemination (ICI) Market
6.3.4.1. Overview
6.3.4.2. Intracervical Insemination (ICI) Market Revenue Forecasts and Analysis (US$ Mn)
6.3.5. Others Market
6.3.5.1. Overview
6.3.5.2. Others Market Revenue Forecasts and Analysis (US$ Mn)
6.4. IN VITRO FERTILIZATION MARKET
6.4.1. Overview
6.4.2. In Vitro Fertilization Market Revenue Forecasts and Analysis (US$ Mn)
6.4.3. Intra-cytoplasmic Sperm Injection (ICSI) Market
6.4.3.1. Overview
6.4.3.2. Intra-cytoplasmic Sperm Injection (ICSI) Market Revenue Forecasts and Analysis (US$ Mn)
6.4.4. Preimplantation Genetic Diagnosis (PGD) Market
6.4.4.1. Overview
6.4.4.2. Preimplantation Genetic Diagnosis (PGD) Market Revenue Forecasts and Analysis (US$ Mn)
6.5. SURROGACY MARKET
6.5.1. Overview
6.5.2. Surrogacy Market Revenue Forecasts and Analysis (US$ Mn)
6.6. OTHER END USER MARKET
6.6.1. Overview
6.6.2. Other End User Market Revenue Forecasts and Analysis (US$ Mn)
7. ASSISTED REPRODUCTIVE TECHNOLOGY MARKET REVENUE AND FORECASTS TO 2027 - BY PROCEDURE
7.1. OVERVIEW
7.2. PROCEDURE MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
7.3. FRESH DONOR MARKET
7.3.1. Overview
7.3.2. Fresh Donor Market Revenue Forecasts and Analysis (US$ Mn)
7.4. FRESH NON DONOR MARKET
7.4.1. Overview
7.4.2. Fresh Non Donor Market Revenue Forecasts and Analysis (US$ Mn)
7.5. FROZEN DONOR MARKET
7.5.1. Overview
7.5.2. Frozen Donor Market Revenue Forecasts and Analysis (US$ Mn)
7.6. FROZEN NON DONOR MARKET
7.6.1. Overview
7.6.2. Frozen Non Donor Market Revenue Forecasts and Analysis (US$ Mn)
7.7. EMBRYO BANKING MARKET
7.7.1. Overview
7.7.2. Embryo Banking Market Revenue Forecasts and Analysis (US$ Mn)
8. ASSISTED REPRODUCTIVE TECHNOLOGY MARKET REVENUE AND FORECASTS TO 2027 - BY END USER
8.1. OVERVIEW
8.2. END USER MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
8.3. FERTILITY CLINICS MARKET
8.3.1. Overview
8.3.2. Fertility Clinics Revenue Forecasts and Analysis (US$ Mn)
8.4. HOSPITALS MARKET
8.4.1. Overview
8.4.2. Hospitals Market Revenue Forecasts and Analysis (US$ Mn)
8.5. OTHER END USER MARKET
8.5.1. Overview
8.5.2. Other End User Market Revenue Forecasts and Analysis (US$ Mn)
9. NORTH AMERICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
9.1. NORTH AMERICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET OVERVIEW
9.2. NORTH AMERICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
9.3. NORTH AMERICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET REVENUE AND FORECASTS ANALYSIS - BY TECHNOLOGY (US$ MN)
9.3.1. North America Artificial Insemination Market Revenue and Forecasts Analysis - By Type (US$ MN)
9.3.2. North America In Vitro Fertilization Market Revenue and Forecasts Analysis - By Type (US$ MN)
9.4. NORTH AMERICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET VOLUME AND FORECASTS ANALYSIS - BY PROCEDURE (US$ MN)
9.5. NORTH AMERICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET VOLUME AND FORECASTS ANALYSIS - BY END USER (US$ MN)
9.6. NORTH AMERICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
9.7. US MARKET OVERVIEW
9.7.1. US Assisted Reproductive Technology Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
9.7.1.1. US Artificial Insemination Market Revenue and Forecasts Analysis - By Type (US$ MN)
9.7.1.2. US In Vitro Fertilization Market Revenue and Forecasts Analysis - By Type (US$ MN)
9.7.2. US Assisted Reproductive Technology Market Revenue Forecasts and Analysis - By Procedure (US$ Mn)
9.7.3. US Assisted Reproductive Technology Market Revenue Forecasts and Analysis - By End User (US$ Mn)
9.8. CANADA MARKET OVERVIEW
9.8.1. Canada Assisted Reproductive Technology Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
9.8.1.1. Canada Artificial Insemination Market Revenue and Forecasts Analysis - By Type (US$ MN)
9.8.1.2. Canada In Vitro Fertilization Market Revenue and Forecasts Analysis - By Type (US$ MN)
9.8.2. Canada Assisted Reproductive Technology Market Revenue Forecasts and Analysis - By Procedure (US$ Mn)
9.8.3. Canada Assisted Reproductive Technology Market Revenue Forecasts and Analysis - By End User (US$ Mn)
9.9. MEXICO MARKET OVERVIEW
9.9.1. Mexico Assisted Reproductive Technology Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
9.9.1.1. Mexico Artificial Insemination Market Revenue and Forecasts Analysis - By Type (US$ MN)
9.9.1.2. Mexico In Vitro Fertilization Market Revenue and Forecasts Analysis - By Type (US$ MN)
9.9.2. Mexico Assisted Reproductive Technology Market Revenue Forecasts and Analysis - By Procedure (US$ Mn)
9.9.3. Mexico Assisted Reproductive Technology Market Revenue Forecasts and Analysis - By End User (US$ Mn)
10. EUROPE ASSISTED REPRODUCTIVE TECHNOLOGY MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
10.1. EUROPE ASSISTED REPRODUCTIVE TECHNOLOGY MARKET OVERVIEW
10.2. EUROPE ASSISTED REPRODUCTIVE TECHNOLOGY MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
10.3. EUROPE ASSISTED REPRODUCTIVE TECHNOLOGY MARKET REVENUE AND FORECASTS ANALYSIS - BY TECHNOLOGY (US$ MN)
10.3.1. Europe Artificial Insemination Market Revenue and Forecasts Analysis - By Type (US$ MN)
10.3.2. Europe In Vitro Fertilization Market Revenue and Forecasts Analysis - By Type (US$ MN)
10.4. EUROPE ASSISTED REPRODUCTIVE TECHNOLOGY MARKET REVENUE AND FORECASTS ANALYSIS - BY PROCEDURE (US$ MN)
10.5. EUROPE ASSISTED REPRODUCTIVE TECHNOLOGY MARKET VOLUME AND FORECASTS ANALYSIS - BY END USER (US$ MN)
10.6. EUROPE ASSISTED REPRODUCTIVE TECHNOLOGY MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
10.7. UK MARKET OVERVIEW
10.7.1. UK Assisted Reproductive Technology Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
10.7.1.1. UK Artificial Insemination Market Revenue and Forecasts Analysis - By Type (US$ MN)
10.7.1.2. UK In Vitro Fertilization Market Revenue and Forecasts Analysis - By Type (US$ MN)
10.7.2. UK Assisted Reproductive Technology Market Revenue Forecasts and Analysis - By Procedure (US$ Mn)
10.7.3. UK Assisted Reproductive Technology Market Revenue Forecasts and Analysis - By End User (US$ Mn)
10.8. GERMANY MARKET OVERVIEW
10.8.1. Germany Assisted Reproductive Technology Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
10.8.1.1. Germany Artificial Insemination Market Revenue and Forecasts Analysis - By Type (US$ MN)
10.8.1.2. Germany In Vitro Fertilization Market Revenue and Forecasts Analysis - By Type (US$ MN)
10.8.2. Germany Assisted Reproductive Technology Market Revenue Forecasts and Analysis - By Procedure (US$ Mn)
10.8.3. Germany Assisted Reproductive Technology Market Revenue Forecasts and Analysis - By End User (US$ Mn)
10.9. FRANCE MARKET OVERVIEW
10.9.1. France Assisted Reproductive Technology Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
10.9.1.1. France Artificial Insemination Market Revenue and Forecasts Analysis - By Type (US$ MN)
10.9.1.2. France In Vitro Fertilization Market Revenue and Forecasts Analysis - By Type (US$ MN)
10.9.2. France Assisted Reproductive Technology Market Revenue Forecasts and Analysis - By Procedure (US$ Mn)
10.9.3. France Assisted Reproductive Technology Market Revenue Forecasts and Analysis - By End User (US$ Mn)
11. ASIA PACIFIC ASSISTED REPRODUCTIVE TECHNOLOGY MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
11.1. ASIA PACIFIC ASSISTED REPRODUCTIVE TECHNOLOGY MARKET OVERVIEW
11.2. ASIA PACIFIC ASSISTED REPRODUCTIVE TECHNOLOGY MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
11.3. ASIA PACIFIC ASSISTED REPRODUCTIVE TECHNOLOGY MARKET REVENUE AND FORECASTS ANALYSIS - BY TECHNOLOGY (US$ MN)
11.3.1. Asia Pacific Artificial Insemination Market Revenue and Forecasts Analysis - By Type (US$ MN)
11.3.2. Asia Pacific In Vitro Fertilization Market Revenue and Forecasts Analysis - By Type (US$ MN)
11.4. ASIA PACIFIC ASSISTED REPRODUCTIVE TECHNOLOGY MARKET REVENUE AND FORECASTS ANALYSIS - BY PROCEDURE (US$ MN)
11.5. ASIA PACIFIC ASSISTED REPRODUCTIVE TECHNOLOGY MARKET VOLUME AND FORECASTS ANALYSIS - BY END USER (US$ MN)
11.6. ASIA PACIFIC ASSISTED REPRODUCTIVE TECHNOLOGY MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
11.7. JAPAN MARKET OVERVIEW
11.7.1. Japan Assisted Reproductive Technology Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
11.7.1.1. Japan Artificial Insemination Market Revenue and Forecasts Analysis - By Type (US$ MN)
11.7.1.2. Japan In Vitro Fertilization Market Revenue and Forecasts Analysis - By Type (US$ MN)
11.7.2. Japan Assisted Reproductive Technology Market Revenue Forecasts and Analysis - By Procedure (US$ Mn)
11.7.3. Japan Assisted Reproductive Technology Market Revenue Forecasts and Analysis - By End User (US$ Mn)
11.8. CHINA MARKET OVERVIEW
11.8.1. China Assisted Reproductive Technology Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
11.8.1.1. China Artificial Insemination Market Revenue and Forecasts Analysis - By Type (US$ MN)
11.8.1.2. China In Vitro Fertilization Market Revenue and Forecasts Analysis - By Type (US$ MN)
11.8.2. China Assisted Reproductive Technology Market Revenue Forecasts and Analysis - By Procedure (US$ Mn)
11.8.3. China Assisted Reproductive Technology Market Revenue Forecasts and Analysis - By End User (US$ Mn)
11.9. INDIA MARKET OVERVIEW
11.9.1. India Assisted Reproductive Technology Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
11.9.1.1. India Artificial Insemination Market Revenue and Forecasts Analysis - By Type (US$ MN)
11.9.1.2. India In Vitro Fertilization Market Revenue and Forecasts Analysis - By Type (US$ MN)
11.9.2. India Assisted Reproductive Technology Market Revenue Forecasts and Analysis - By Procedure (US$ Mn)
11.9.3. India Assisted Reproductive Technology Market Revenue Forecasts and Analysis - By End User (US$ Mn)
12. MIDDLE EAST AND AFRICA (MEA) ASSISTED REPRODUCTIVE TECHNOLOGY MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
12.1. MIDDLE EAST AND AFRICA (MEA) ASSISTED REPRODUCTIVE TECHNOLOGY MARKET OVERVIEW
12.2. MIDDLE EAST AND AFRICA (MEA) ASSISTED REPRODUCTIVE TECHNOLOGY MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
12.3. MIDDLE EAST AND AFRICA (MEA) ASSISTED REPRODUCTIVE TECHNOLOGY MARKET REVENUE AND FORECASTS ANALYSIS - BY TECHNOLOGY (US$ MN)
12.3.1. Middle East and Africa (MEA)Artificial Insemination Market Revenue and Forecasts Analysis - By Type (US$ MN)
12.3.2. Middle East and Africa (MEA)In Vitro Fertilization Market Revenue and Forecasts Analysis - By Type (US$ MN)
12.4. MIDDLE EAST AND AFRICA (MEA)ASSISTED REPRODUCTIVE TECHNOLOGY MARKET REVENUE AND FORECASTS ANALYSIS - BY PROCEDURE (US$ MN)
12.5. MIDDLE EAST AND AFRICA (MEA)ASSISTED REPRODUCTIVE TECHNOLOGY MARKET VOLUME AND FORECASTS ANALYSIS - BY END USER (US$ MN)
12.6. MIDDLE EAST AND AFRICA (MEA)ASSISTED REPRODUCTIVE TECHNOLOGY MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
12.7. SOUTH AFRICA MARKET OVERVIEW
12.7.1. South Africa Assisted Reproductive Technology Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
12.7.1.1. South Africa Artificial Insemination Market Revenue and Forecasts Analysis - By Type (US$ MN)
12.7.1.2. South Africa In Vitro Fertilization Market Revenue and Forecasts Analysis - By Type (US$ MN)
12.7.2. South Africa Assisted Reproductive Technology Market Revenue Forecasts and Analysis - By Procedure (US$ Mn)
12.7.3. South Africa Assisted Reproductive Technology Market Revenue Forecasts and Analysis - By End User (US$ Mn)
12.8. SAUDI ARABIA MARKET OVERVIEW
12.8.1. Saudi Arabia Assisted Reproductive Technology Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
12.8.1.1. Saudi Arabia Artificial Insemination Market Revenue and Forecasts Analysis - By Type (US$ MN)
12.8.1.2. Saudi Arabia In Vitro Fertilization Market Revenue and Forecasts Analysis - By Type (US$ MN)
12.8.2. Saudi Arabia Assisted Reproductive Technology Market Revenue Forecasts and Analysis - By Procedure (US$ Mn)
12.8.3. Saudi Arabia Assisted Reproductive Technology Market Revenue Forecasts and Analysis - By End User (US$ Mn)
12.9. UAE MARKET OVERVIEW
12.9.1. UAE Assisted Reproductive Technology Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
12.9.1.1. UAE Artificial Insemination Market Revenue and Forecasts Analysis - By Type (US$ MN)
12.9.1.2. UAE In Vitro Fertilization Market Revenue and Forecasts Analysis - By Type (US$ MN)
12.9.2. UAE Assisted Reproductive Technology Market Revenue Forecasts and Analysis - By Procedure (US$ Mn)
12.9.3. UAE Assisted Reproductive Technology Market Revenue Forecasts and Analysis - By End User (US$ Mn)
13. SOUTH AND CENTRAL AMERICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
13.1. SOUTH AND CENTRAL AMERICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET OVERVIEW
13.2. SOUTH AND CENTRAL AMERICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
13.3. SOUTH AND CENTRAL AMERICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET REVENUE AND FORECASTS ANALYSIS - BY TECHNOLOGY (US$ MN)
13.3.1. South and Central America Artificial Insemination Market Revenue and Forecasts Analysis - By Type (US$ MN)
13.3.2. South and Central America In Vitro Fertilization Market Revenue and Forecasts Analysis - By Type (US$ MN)
13.4. SOUTH AND CENTRAL AMERICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET REVENUE AND FORECASTS ANALYSIS - BY PROCEDURE (US$ MN)
13.5. SOUTH AND CENTRAL AMERICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET VOLUME AND FORECASTS ANALYSIS - BY END USER (US$ MN)
13.6. SOUTH AND CENTRAL AMERICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
13.7. BRAZIL MARKET OVERVIEW
13.7.1. Brazil Assisted Reproductive Technology Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
13.7.1.1. Brazil Artificial Insemination Market Revenue and Forecasts Analysis - By Type (US$ MN)
13.7.1.2. Brazil In Vitro Fertilization Market Revenue and Forecasts Analysis - By Type (US$ MN)
13.7.2. Brazil Assisted Reproductive Technology Market Revenue Forecasts and Analysis - By Procedure (US$ Mn)
13.7.3. Brazil Assisted Reproductive Technology Market Revenue Forecasts and Analysis - By End User (US$ Mn)
14. INDUSTRY LANDSCAPE
14.1. ORGANIC GROWTH STRATEGIES
14.1.1. New Product Launches
14.1.2. Marketing & Promotional Activities
14.2. INORGANIC GROWTH STRATEGIES
14.2.1. Partnerships, Collaborations, and Joint Ventures
14.2.2. Mergers & Acquisitions
15. ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, KEY COMPANY PROFILES
15.1. Cosmos Biomedical Ltd.
15.1.1. Key Facts
15.1.2. Business Description
15.1.3. Financial Overview
15.1.4. Product Portfolio
15.1.5. Product Pipeline
15.1.6. SWOT Analysis
15.1.7. Key Developments
15.2. Microm Ltd.
15.2.1. Key Facts
15.2.2. Business Description
15.2.3. Financial Overview
15.2.4. Product Portfolio
15.2.5. Product Pipeline
15.2.6. SWOT Analysis
15.2.7. Key Developments
15.3. Irvine Scientific
15.3.1. Key Facts
15.3.2. Business Description
15.3.3. Financial Overview
15.3.4. Product Portfolio
15.3.5. Product Pipeline
15.3.6. SWOT Analysis
15.3.7. Key Developments
15.4. Parallabs Ltd
15.4.1. Key Facts
15.4.2. Business Description
15.4.3. Financial Overview
15.4.4. Product Portfolio
15.4.5. Product Pipeline
15.4.6. SWOT Analysis
15.4.7. Key Developments
15.5. Bloom Fertility Centre
15.5.1. Key Facts
15.5.2. Business Description
15.5.3. Financial Overview
15.5.4. Product Portfolio
15.5.5. Product Pipeline
15.5.6. SWOT Analysis
15.5.7. Key Developments
15.6. Ferring B.V.
15.6.1. Key Facts
15.6.2. Business Description
15.6.3. Financial Overview
15.6.4. Product Portfolio
15.6.5. Product Pipeline
15.6.6. SWOT Analysis
15.6.7. Key Developments
15.7. OvaScience, Inc
15.7.1. Key Facts
15.7.2. Business Description
15.7.3. Financial Overview
15.7.4. Product Portfolio
15.7.5. Product Pipeline
15.7.6. SWOT Analysis
15.7.7. Key Developments
15.8. KITAZATO CORPORATION.
15.8.1. Key Facts
15.8.2. Business Description
15.8.3. Financial Overview
15.8.4. Product Portfolio
15.8.5. Product Pipeline
15.8.6. SWOT Analysis
15.8.7. Key Developments
15.9. Vitrolife
15.9.1. Key Facts
15.9.2. Business Description
15.9.3. Financial Overview
15.9.4. Product Portfolio
15.9.5. Product Pipeline
15.9.6. SWOT Analysis
15.9.7. Key Developments
15.10. CooperSurgical Inc.
15.10.1. Key Facts
15.10.2. Business Description
15.10.3. Financial Overview
15.10.4. Product Portfolio
15.10.5. Product Pipeline
15.10.6. SWOT Analysis
15.10.7. Key Developments
16. APPENDIX
16.1. ABOUT THE INSIGHT PARTNERS
16.2. GLOSSARY OF TERMS
16.3. RESEARCH METHODOLOGY
1. INTRODUCTION
1.1. SCOPE OF STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
2. KEY TAKEAWAYS
3. ASSISTED REPRODUCTIVE TECHNOLOGY MARKET LANDSCAPE
3.1. MARKET OVERVIEW
3.2. MARKET SEGMENTATION
3.2.1. Assisted Reproductive Technology Market - By Technology
3.2.2. Assisted Reproductive Technology Market - By Procedure
3.2.3. Assisted Reproductive Technology Market - By End User
3.2.4. Assisted Reproductive Technology Market - By Region
3.2.4.1. By Country
3.3. PEST ANALYSIS
3.3.1. North America - PEST Analysis
3.3.2. Europe - PEST Analysis
3.3.3. Asia Pacific - PEST Analysis
3.3.4. Middle East and Africa - PEST Analysis
3.3.5. South and Central America- PEST Analysis
4. ASSISTED REPRODUCTIVE TECHNOLOGY MARKET - KEY INDUSTRY DYNAMICS
4.1. KEY MARKET DRIVERS
4.2. KEY MARKET RESTRAINTS
4.3. KEY MARKET OPPORTUNITIES
4.4. FUTURE TRENDS
4.5. IMPACT ANALYSIS
5. ASSISTED REPRODUCTIVE TECHNOLOGY MARKET - GLOBAL ANALYSIS
5.1. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET OVERVIEW
5.2. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
5.3. MARKET POSITIONING/MARKET SHARE
5.4. PERFORMANCE OF KEY PLAYERS
5.5. CLINICAL TRIALS
5.6. EXPERT OPINIONS
6. ASSISTED REPRODUCTIVE TECHNOLOGY MARKET REVENUE AND FORECASTS TO 2027 - BY TECHNOLOGY
6.1. OVERVIEW
6.2. TECHNOLOGY MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
6.3. ARTIFICIAL INSEMINATION MARKET
6.3.1. Overview
6.3.2. Artificial Insemination Market Revenue Forecasts and Analysis (US$ Mn)
6.3.3. Intrauterine Insemination (IUI) Market
6.3.3.1. Overview
6.3.3.2. Intrauterine Insemination (IUI) Market Revenue Forecasts and Analysis (US$ Mn)
6.3.4. Intracervical Insemination (ICI) Market
6.3.4.1. Overview
6.3.4.2. Intracervical Insemination (ICI) Market Revenue Forecasts and Analysis (US$ Mn)
6.3.5. Others Market
6.3.5.1. Overview
6.3.5.2. Others Market Revenue Forecasts and Analysis (US$ Mn)
6.4. IN VITRO FERTILIZATION MARKET
6.4.1. Overview
6.4.2. In Vitro Fertilization Market Revenue Forecasts and Analysis (US$ Mn)
6.4.3. Intra-cytoplasmic Sperm Injection (ICSI) Market
6.4.3.1. Overview
6.4.3.2. Intra-cytoplasmic Sperm Injection (ICSI) Market Revenue Forecasts and Analysis (US$ Mn)
6.4.4. Preimplantation Genetic Diagnosis (PGD) Market
6.4.4.1. Overview
6.4.4.2. Preimplantation Genetic Diagnosis (PGD) Market Revenue Forecasts and Analysis (US$ Mn)
6.5. SURROGACY MARKET
6.5.1. Overview
6.5.2. Surrogacy Market Revenue Forecasts and Analysis (US$ Mn)
6.6. OTHER END USER MARKET
6.6.1. Overview
6.6.2. Other End User Market Revenue Forecasts and Analysis (US$ Mn)
7. ASSISTED REPRODUCTIVE TECHNOLOGY MARKET REVENUE AND FORECASTS TO 2027 - BY PROCEDURE
7.1. OVERVIEW
7.2. PROCEDURE MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
7.3. FRESH DONOR MARKET
7.3.1. Overview
7.3.2. Fresh Donor Market Revenue Forecasts and Analysis (US$ Mn)
7.4. FRESH NON DONOR MARKET
7.4.1. Overview
7.4.2. Fresh Non Donor Market Revenue Forecasts and Analysis (US$ Mn)
7.5. FROZEN DONOR MARKET
7.5.1. Overview
7.5.2. Frozen Donor Market Revenue Forecasts and Analysis (US$ Mn)
7.6. FROZEN NON DONOR MARKET
7.6.1. Overview
7.6.2. Frozen Non Donor Market Revenue Forecasts and Analysis (US$ Mn)
7.7. EMBRYO BANKING MARKET
7.7.1. Overview
7.7.2. Embryo Banking Market Revenue Forecasts and Analysis (US$ Mn)
8. ASSISTED REPRODUCTIVE TECHNOLOGY MARKET REVENUE AND FORECASTS TO 2027 - BY END USER
8.1. OVERVIEW
8.2. END USER MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
8.3. FERTILITY CLINICS MARKET
8.3.1. Overview
8.3.2. Fertility Clinics Revenue Forecasts and Analysis (US$ Mn)
8.4. HOSPITALS MARKET
8.4.1. Overview
8.4.2. Hospitals Market Revenue Forecasts and Analysis (US$ Mn)
8.5. OTHER END USER MARKET
8.5.1. Overview
8.5.2. Other End User Market Revenue Forecasts and Analysis (US$ Mn)
9. NORTH AMERICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
9.1. NORTH AMERICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET OVERVIEW
9.2. NORTH AMERICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
9.3. NORTH AMERICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET REVENUE AND FORECASTS ANALYSIS - BY TECHNOLOGY (US$ MN)
9.3.1. North America Artificial Insemination Market Revenue and Forecasts Analysis - By Type (US$ MN)
9.3.2. North America In Vitro Fertilization Market Revenue and Forecasts Analysis - By Type (US$ MN)
9.4. NORTH AMERICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET VOLUME AND FORECASTS ANALYSIS - BY PROCEDURE (US$ MN)
9.5. NORTH AMERICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET VOLUME AND FORECASTS ANALYSIS - BY END USER (US$ MN)
9.6. NORTH AMERICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
9.7. US MARKET OVERVIEW
9.7.1. US Assisted Reproductive Technology Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
9.7.1.1. US Artificial Insemination Market Revenue and Forecasts Analysis - By Type (US$ MN)
9.7.1.2. US In Vitro Fertilization Market Revenue and Forecasts Analysis - By Type (US$ MN)
9.7.2. US Assisted Reproductive Technology Market Revenue Forecasts and Analysis - By Procedure (US$ Mn)
9.7.3. US Assisted Reproductive Technology Market Revenue Forecasts and Analysis - By End User (US$ Mn)
9.8. CANADA MARKET OVERVIEW
9.8.1. Canada Assisted Reproductive Technology Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
9.8.1.1. Canada Artificial Insemination Market Revenue and Forecasts Analysis - By Type (US$ MN)
9.8.1.2. Canada In Vitro Fertilization Market Revenue and Forecasts Analysis - By Type (US$ MN)
9.8.2. Canada Assisted Reproductive Technology Market Revenue Forecasts and Analysis - By Procedure (US$ Mn)
9.8.3. Canada Assisted Reproductive Technology Market Revenue Forecasts and Analysis - By End User (US$ Mn)
9.9. MEXICO MARKET OVERVIEW
9.9.1. Mexico Assisted Reproductive Technology Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
9.9.1.1. Mexico Artificial Insemination Market Revenue and Forecasts Analysis - By Type (US$ MN)
9.9.1.2. Mexico In Vitro Fertilization Market Revenue and Forecasts Analysis - By Type (US$ MN)
9.9.2. Mexico Assisted Reproductive Technology Market Revenue Forecasts and Analysis - By Procedure (US$ Mn)
9.9.3. Mexico Assisted Reproductive Technology Market Revenue Forecasts and Analysis - By End User (US$ Mn)
10. EUROPE ASSISTED REPRODUCTIVE TECHNOLOGY MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
10.1. EUROPE ASSISTED REPRODUCTIVE TECHNOLOGY MARKET OVERVIEW
10.2. EUROPE ASSISTED REPRODUCTIVE TECHNOLOGY MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
10.3. EUROPE ASSISTED REPRODUCTIVE TECHNOLOGY MARKET REVENUE AND FORECASTS ANALYSIS - BY TECHNOLOGY (US$ MN)
10.3.1. Europe Artificial Insemination Market Revenue and Forecasts Analysis - By Type (US$ MN)
10.3.2. Europe In Vitro Fertilization Market Revenue and Forecasts Analysis - By Type (US$ MN)
10.4. EUROPE ASSISTED REPRODUCTIVE TECHNOLOGY MARKET REVENUE AND FORECASTS ANALYSIS - BY PROCEDURE (US$ MN)
10.5. EUROPE ASSISTED REPRODUCTIVE TECHNOLOGY MARKET VOLUME AND FORECASTS ANALYSIS - BY END USER (US$ MN)
10.6. EUROPE ASSISTED REPRODUCTIVE TECHNOLOGY MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
10.7. UK MARKET OVERVIEW
10.7.1. UK Assisted Reproductive Technology Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
10.7.1.1. UK Artificial Insemination Market Revenue and Forecasts Analysis - By Type (US$ MN)
10.7.1.2. UK In Vitro Fertilization Market Revenue and Forecasts Analysis - By Type (US$ MN)
10.7.2. UK Assisted Reproductive Technology Market Revenue Forecasts and Analysis - By Procedure (US$ Mn)
10.7.3. UK Assisted Reproductive Technology Market Revenue Forecasts and Analysis - By End User (US$ Mn)
10.8. GERMANY MARKET OVERVIEW
10.8.1. Germany Assisted Reproductive Technology Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
10.8.1.1. Germany Artificial Insemination Market Revenue and Forecasts Analysis - By Type (US$ MN)
10.8.1.2. Germany In Vitro Fertilization Market Revenue and Forecasts Analysis - By Type (US$ MN)
10.8.2. Germany Assisted Reproductive Technology Market Revenue Forecasts and Analysis - By Procedure (US$ Mn)
10.8.3. Germany Assisted Reproductive Technology Market Revenue Forecasts and Analysis - By End User (US$ Mn)
10.9. FRANCE MARKET OVERVIEW
10.9.1. France Assisted Reproductive Technology Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
10.9.1.1. France Artificial Insemination Market Revenue and Forecasts Analysis - By Type (US$ MN)
10.9.1.2. France In Vitro Fertilization Market Revenue and Forecasts Analysis - By Type (US$ MN)
10.9.2. France Assisted Reproductive Technology Market Revenue Forecasts and Analysis - By Procedure (US$ Mn)
10.9.3. France Assisted Reproductive Technology Market Revenue Forecasts and Analysis - By End User (US$ Mn)
11. ASIA PACIFIC ASSISTED REPRODUCTIVE TECHNOLOGY MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
11.1. ASIA PACIFIC ASSISTED REPRODUCTIVE TECHNOLOGY MARKET OVERVIEW
11.2. ASIA PACIFIC ASSISTED REPRODUCTIVE TECHNOLOGY MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
11.3. ASIA PACIFIC ASSISTED REPRODUCTIVE TECHNOLOGY MARKET REVENUE AND FORECASTS ANALYSIS - BY TECHNOLOGY (US$ MN)
11.3.1. Asia Pacific Artificial Insemination Market Revenue and Forecasts Analysis - By Type (US$ MN)
11.3.2. Asia Pacific In Vitro Fertilization Market Revenue and Forecasts Analysis - By Type (US$ MN)
11.4. ASIA PACIFIC ASSISTED REPRODUCTIVE TECHNOLOGY MARKET REVENUE AND FORECASTS ANALYSIS - BY PROCEDURE (US$ MN)
11.5. ASIA PACIFIC ASSISTED REPRODUCTIVE TECHNOLOGY MARKET VOLUME AND FORECASTS ANALYSIS - BY END USER (US$ MN)
11.6. ASIA PACIFIC ASSISTED REPRODUCTIVE TECHNOLOGY MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
11.7. JAPAN MARKET OVERVIEW
11.7.1. Japan Assisted Reproductive Technology Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
11.7.1.1. Japan Artificial Insemination Market Revenue and Forecasts Analysis - By Type (US$ MN)
11.7.1.2. Japan In Vitro Fertilization Market Revenue and Forecasts Analysis - By Type (US$ MN)
11.7.2. Japan Assisted Reproductive Technology Market Revenue Forecasts and Analysis - By Procedure (US$ Mn)
11.7.3. Japan Assisted Reproductive Technology Market Revenue Forecasts and Analysis - By End User (US$ Mn)
11.8. CHINA MARKET OVERVIEW
11.8.1. China Assisted Reproductive Technology Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
11.8.1.1. China Artificial Insemination Market Revenue and Forecasts Analysis - By Type (US$ MN)
11.8.1.2. China In Vitro Fertilization Market Revenue and Forecasts Analysis - By Type (US$ MN)
11.8.2. China Assisted Reproductive Technology Market Revenue Forecasts and Analysis - By Procedure (US$ Mn)
11.8.3. China Assisted Reproductive Technology Market Revenue Forecasts and Analysis - By End User (US$ Mn)
11.9. INDIA MARKET OVERVIEW
11.9.1. India Assisted Reproductive Technology Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
11.9.1.1. India Artificial Insemination Market Revenue and Forecasts Analysis - By Type (US$ MN)
11.9.1.2. India In Vitro Fertilization Market Revenue and Forecasts Analysis - By Type (US$ MN)
11.9.2. India Assisted Reproductive Technology Market Revenue Forecasts and Analysis - By Procedure (US$ Mn)
11.9.3. India Assisted Reproductive Technology Market Revenue Forecasts and Analysis - By End User (US$ Mn)
12. MIDDLE EAST AND AFRICA (MEA) ASSISTED REPRODUCTIVE TECHNOLOGY MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
12.1. MIDDLE EAST AND AFRICA (MEA) ASSISTED REPRODUCTIVE TECHNOLOGY MARKET OVERVIEW
12.2. MIDDLE EAST AND AFRICA (MEA) ASSISTED REPRODUCTIVE TECHNOLOGY MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
12.3. MIDDLE EAST AND AFRICA (MEA) ASSISTED REPRODUCTIVE TECHNOLOGY MARKET REVENUE AND FORECASTS ANALYSIS - BY TECHNOLOGY (US$ MN)
12.3.1. Middle East and Africa (MEA)Artificial Insemination Market Revenue and Forecasts Analysis - By Type (US$ MN)
12.3.2. Middle East and Africa (MEA)In Vitro Fertilization Market Revenue and Forecasts Analysis - By Type (US$ MN)
12.4. MIDDLE EAST AND AFRICA (MEA)ASSISTED REPRODUCTIVE TECHNOLOGY MARKET REVENUE AND FORECASTS ANALYSIS - BY PROCEDURE (US$ MN)
12.5. MIDDLE EAST AND AFRICA (MEA)ASSISTED REPRODUCTIVE TECHNOLOGY MARKET VOLUME AND FORECASTS ANALYSIS - BY END USER (US$ MN)
12.6. MIDDLE EAST AND AFRICA (MEA)ASSISTED REPRODUCTIVE TECHNOLOGY MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
12.7. SOUTH AFRICA MARKET OVERVIEW
12.7.1. South Africa Assisted Reproductive Technology Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
12.7.1.1. South Africa Artificial Insemination Market Revenue and Forecasts Analysis - By Type (US$ MN)
12.7.1.2. South Africa In Vitro Fertilization Market Revenue and Forecasts Analysis - By Type (US$ MN)
12.7.2. South Africa Assisted Reproductive Technology Market Revenue Forecasts and Analysis - By Procedure (US$ Mn)
12.7.3. South Africa Assisted Reproductive Technology Market Revenue Forecasts and Analysis - By End User (US$ Mn)
12.8. SAUDI ARABIA MARKET OVERVIEW
12.8.1. Saudi Arabia Assisted Reproductive Technology Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
12.8.1.1. Saudi Arabia Artificial Insemination Market Revenue and Forecasts Analysis - By Type (US$ MN)
12.8.1.2. Saudi Arabia In Vitro Fertilization Market Revenue and Forecasts Analysis - By Type (US$ MN)
12.8.2. Saudi Arabia Assisted Reproductive Technology Market Revenue Forecasts and Analysis - By Procedure (US$ Mn)
12.8.3. Saudi Arabia Assisted Reproductive Technology Market Revenue Forecasts and Analysis - By End User (US$ Mn)
12.9. UAE MARKET OVERVIEW
12.9.1. UAE Assisted Reproductive Technology Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
12.9.1.1. UAE Artificial Insemination Market Revenue and Forecasts Analysis - By Type (US$ MN)
12.9.1.2. UAE In Vitro Fertilization Market Revenue and Forecasts Analysis - By Type (US$ MN)
12.9.2. UAE Assisted Reproductive Technology Market Revenue Forecasts and Analysis - By Procedure (US$ Mn)
12.9.3. UAE Assisted Reproductive Technology Market Revenue Forecasts and Analysis - By End User (US$ Mn)
13. SOUTH AND CENTRAL AMERICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET REVENUE AND FORECASTS TO 2027 - COUNTRY ANALYSIS
13.1. SOUTH AND CENTRAL AMERICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET OVERVIEW
13.2. SOUTH AND CENTRAL AMERICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
13.3. SOUTH AND CENTRAL AMERICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET REVENUE AND FORECASTS ANALYSIS - BY TECHNOLOGY (US$ MN)
13.3.1. South and Central America Artificial Insemination Market Revenue and Forecasts Analysis - By Type (US$ MN)
13.3.2. South and Central America In Vitro Fertilization Market Revenue and Forecasts Analysis - By Type (US$ MN)
13.4. SOUTH AND CENTRAL AMERICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET REVENUE AND FORECASTS ANALYSIS - BY PROCEDURE (US$ MN)
13.5. SOUTH AND CENTRAL AMERICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET VOLUME AND FORECASTS ANALYSIS - BY END USER (US$ MN)
13.6. SOUTH AND CENTRAL AMERICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
13.7. BRAZIL MARKET OVERVIEW
13.7.1. Brazil Assisted Reproductive Technology Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
13.7.1.1. Brazil Artificial Insemination Market Revenue and Forecasts Analysis - By Type (US$ MN)
13.7.1.2. Brazil In Vitro Fertilization Market Revenue and Forecasts Analysis - By Type (US$ MN)
13.7.2. Brazil Assisted Reproductive Technology Market Revenue Forecasts and Analysis - By Procedure (US$ Mn)
13.7.3. Brazil Assisted Reproductive Technology Market Revenue Forecasts and Analysis - By End User (US$ Mn)
14. INDUSTRY LANDSCAPE
14.1. ORGANIC GROWTH STRATEGIES
14.1.1. New Product Launches
14.1.2. Marketing & Promotional Activities
14.2. INORGANIC GROWTH STRATEGIES
14.2.1. Partnerships, Collaborations, and Joint Ventures
14.2.2. Mergers & Acquisitions
15. ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, KEY COMPANY PROFILES
15.1. Cosmos Biomedical Ltd.
15.1.1. Key Facts
15.1.2. Business Description
15.1.3. Financial Overview
15.1.4. Product Portfolio
15.1.5. Product Pipeline
15.1.6. SWOT Analysis
15.1.7. Key Developments
15.2. Microm Ltd.
15.2.1. Key Facts
15.2.2. Business Description
15.2.3. Financial Overview
15.2.4. Product Portfolio
15.2.5. Product Pipeline
15.2.6. SWOT Analysis
15.2.7. Key Developments
15.3. Irvine Scientific
15.3.1. Key Facts
15.3.2. Business Description
15.3.3. Financial Overview
15.3.4. Product Portfolio
15.3.5. Product Pipeline
15.3.6. SWOT Analysis
15.3.7. Key Developments
15.4. Parallabs Ltd
15.4.1. Key Facts
15.4.2. Business Description
15.4.3. Financial Overview
15.4.4. Product Portfolio
15.4.5. Product Pipeline
15.4.6. SWOT Analysis
15.4.7. Key Developments
15.5. Bloom Fertility Centre
15.5.1. Key Facts
15.5.2. Business Description
15.5.3. Financial Overview
15.5.4. Product Portfolio
15.5.5. Product Pipeline
15.5.6. SWOT Analysis
15.5.7. Key Developments
15.6. Ferring B.V.
15.6.1. Key Facts
15.6.2. Business Description
15.6.3. Financial Overview
15.6.4. Product Portfolio
15.6.5. Product Pipeline
15.6.6. SWOT Analysis
15.6.7. Key Developments
15.7. OvaScience, Inc
15.7.1. Key Facts
15.7.2. Business Description
15.7.3. Financial Overview
15.7.4. Product Portfolio
15.7.5. Product Pipeline
15.7.6. SWOT Analysis
15.7.7. Key Developments
15.8. KITAZATO CORPORATION.
15.8.1. Key Facts
15.8.2. Business Description
15.8.3. Financial Overview
15.8.4. Product Portfolio
15.8.5. Product Pipeline
15.8.6. SWOT Analysis
15.8.7. Key Developments
15.9. Vitrolife
15.9.1. Key Facts
15.9.2. Business Description
15.9.3. Financial Overview
15.9.4. Product Portfolio
15.9.5. Product Pipeline
15.9.6. SWOT Analysis
15.9.7. Key Developments
15.10. CooperSurgical Inc.
15.10.1. Key Facts
15.10.2. Business Description
15.10.3. Financial Overview
15.10.4. Product Portfolio
15.10.5. Product Pipeline
15.10.6. SWOT Analysis
15.10.7. Key Developments
16. APPENDIX
16.1. ABOUT THE INSIGHT PARTNERS
16.2. GLOSSARY OF TERMS
16.3. RESEARCH METHODOLOGY
The List of Companies
1. Cosmos Biomedical Ltd.
2. Microm Ltd.
3. Irvine Scientific
4. Parallabs Ltd
5. Bloom Fertility Centre
6. Ferring B.V.
7. OvaScience, Inc
8. KITAZATO CORPORATION.
9. Vitrolife
10. CooperSurgical Inc.
1. Cosmos Biomedical Ltd.
2. Microm Ltd.
3. Irvine Scientific
4. Parallabs Ltd
5. Bloom Fertility Centre
6. Ferring B.V.
7. OvaScience, Inc
8. KITAZATO CORPORATION.
9. Vitrolife
10. CooperSurgical Inc.